Search This Blog

Thursday, October 8, 2026

Pacira BioSciences to be acquired by Viatris for $36.50 per share in cash

 

 under definitive agreement

  • Transaction values Pacira BioSciences at approximately $1.65 billion based on the agreed per-share cash consideration
  • Deal is structured as a tender offer followed by a subsequent merger with Viatris
  • Closing of the transaction is expected to occur by the end of 2026
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)